Group items tagged

The safety of HBOT was also evaluated and it was pointed out that, if given at proper paradigms, like 1.5 ATA for 60 minutes, HBOT will not cause oxygen toxicity

Rockswold et al., on the other hand, found that HBOT might be potentially beneficial for severe TBI patients

McDonagh et al., concluded that there was insufficient evidence to establish the effectiveness of HBOT in the treatment of TBI

The first multicenter, randomized, double-blind, controlled trial in 2009 found that 40-hour HBOT of 24% oxygen at 1.3 ATM produced significant improvement in children's overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to those received slightly pressurized room air

Another study in 2010 on 16 autism patients, adopting a similar treatment paradigm, showed no effect on a wide array of behavioral evaluations

To date, there is little evidence that HBOT causes malignant growth or metastasis. A history of malignancy should therefore not be considered as a contraindication for HBOT

HBOT enhances the production of reactive oxygen species (ROS) and causes oxidative stress in body tissues

Excessive accumulation of oxidative stress may contribute to neurodegenerative processes and cell death in the brain, as seen in diseases like Alzheimer's disease (AD) and Parkinson's disease (PD)

Hormesis

process that results in a functional improvement of cellular stress resistance, survival, and longevity in response to sub-lethal levels of stress